<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(8)</volume><submitter>Plattel W</submitter><journal>HemaSphere</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12371470</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Serum TARC dynamics during anti‐PD1‐based first‐line Hodgkin lymphoma treatment: An analysis from the GHSG NIVAHL trial</pubmed_title><pmcid>PMC12371470</pmcid><pubmed_authors>Borchmann P</pubmed_authors><pubmed_authors>Plattel W</pubmed_authors><pubmed_authors>Voltin C</pubmed_authors><pubmed_authors>Kroesen B</pubmed_authors><pubmed_authors>Brockelmann P</pubmed_authors><pubmed_authors>Teesink S</pubmed_authors><pubmed_authors>Visser L</pubmed_authors><pubmed_authors>Schloßer H</pubmed_authors><pubmed_authors>Diepstra A</pubmed_authors><pubmed_authors>von Tresckow B</pubmed_authors><pubmed_authors>Kaul H</pubmed_authors><pubmed_authors>Kobe C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serum TARC dynamics during anti‐PD1‐based first‐line Hodgkin lymphoma treatment: An analysis from the GHSG NIVAHL trial</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-09T10:41:58.93Z</modification><creation>2026-04-08T00:49:00.013Z</creation></dates><accession>S-EPMC12371470</accession><cross_references/></HashMap>